The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Contribution of Circulating Lipids to the Improved Outcome of Critical Illness by Glycemic Control with Intensive Insulin Therapy
Open accessAbstract
Compared with the conventional approach, which recommended only insulin therapy when blood glucose levels exceeded 12 mmol/liter, strict maintenance of blood glucose levels less than 6.1 mmol/liter with intensive insulin therapy has shown to reduce intensive care mortality, acute renal failure, critical illness polyneuropathy, and bloodstream infections in critically ill patients by about 40%. This study of 363 patients, requiring intensive care for more than 7 d and randomly assigned to either conventional or intensive insulin therapy, examines the effects of intensive insulin therapy on glucose and lipid homeostasis and their respective impact on the improved outcome. Intensive insulin therapy effectively normalized blood glucose levels within 24 h, both in survivors and nonsurvivors. Intensive insulin therapy also increased serum levels of low-density lipoprotein (P = 0.007) and high-density lipoprotein (P = 0.005), whereas it suppressed the elevated serum triglyceride concentrations (P < 0.0001). Multivariate logistic regression analysis, corrected for baseline univariate risk factors and the effect on inflammation, indicated that lipid rather than glucose control independently determined the beneficial effects of intensive insulin therapy on morbidity and mortality. In postmortem biopsies obtained from 74 patients who died in the intensive care unit, intensive insulin therapy increased mRNA levels of skeletal muscle glucose transporter 4 (P = 0.02) and hexokinase (P = 0.03), unlike those of hepatic glucokinase. In conclusion, our data suggest that intensive insulin therapy normalizes blood glucose levels through stimulation of peripheral glucose uptake and concomitantly partially restores the abnormalities in the serum lipid profile, which may have contributed significantly to the improved outcome of protracted critical illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Self-citationSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Van den Berghe, G., Wouters, P. J., Bouillon, R., Weekers, F., Verwaest, C., Schetz, M., Vlasselaers, D., Ferdinande, P., & Lauwers, P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045568.12881.10 · Cited by 1,455
Self-citationPostic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Shimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L., & Brown, M. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119247 · Cited by 760
Role of cholesterol in lipid raft formation: lessons from lipid model systems
Silvius, J. R. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00016-6 · Cited by 582
Hansen, T. K., Thiel, S., Wouters, P. J., Christiansen, J. S., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021478 · Cited by 499
Self-citationInfection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins
Khovidhunkit, Memon, R. A., Feingold, K. R., & Grunfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403
Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus
Petersen, K. F., & Shulman, G. I. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02554-7 · Cited by 392
Feingold, K., Staprans, I., Memon, R., Moser, A., Shigenaga, J., Doerrler, W., Dinarello, C., & Grunfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346
Overfeeding Macronutrients to Critically Ill Adults
KLEIN, C. J., STANEK, G. S., & WILES, C. E. (1998) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(98)00179-5 · Cited by 344
Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 320
Iynedjian, P. B., Jotterand, D., Nouspikel, T., Asfari, M., & Pilot, P. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88258-1 · Cited by 257
Preiss-Landl, K., Zimmermann, R., Hämmerle, G., & Zechner, R. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00002 · Cited by 240
Harris, H. W., Grunfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., & Rapp, J. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116259 · Cited by 214
Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver
Ferre, T., Riu, E., Bosch, F., & Valera, A. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.10.8751724 · Cited by 210
Van Lenten, B. J., Fogelman, A. M., Haberland, M. E., & Edwards, P. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2704 · Cited by 185
Feingold, K. R., Krauss, R. M., Pang, M., Doerrler, W., Jensen, P., & Grunfeld, C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501146 · Cited by 183
Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia
Gordon, B. R., Parker, T. S., Levine, D. M., Saal, S. D., Wang, J. C. L., Sloan, B.-J., Barie, P. S., & Rubin, A. L. (1996) · Critical Care Medicine · doi:10.1097/00003246-199604000-00006 · Cited by 183
Changes in the concentration and composition of plasma lipoproteins during the acute phase response
Carpentier, Y. A., & Scruel, O. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200203000-00006 · Cited by 148
Regulation of Insulin-Like Growth Factor Binding Protein-1 during Protracted Critical Illness
Mesotten, D., Delhanty, P. J. D., Vanderhoydonc, F., Hardman, K. V., Weekers, F., Baxter, R. C., & den Berghe, G. V. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020664 · Cited by 142
Self-citationChanges in Intermediary Metabolism in Severe Surgical Illness
Wolfe, R. R., & Martini, W. Z. (2000) · World Journal of Surgery · doi:10.1007/s002689910105 · Cited by 87
Hypocholesterolemia and risk of death in the critically ill surgical patient
Gui, D., Spada, P. L., Gaetano, A. D., & Pacelli, F. (1996) · Intensive Care Medicine · doi:10.1007/bf01709522 · Cited by 86
Memon, R. A., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102516200 · Cited by 85
Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients
Giovannini, I., Boldrini, G., Chiarla, C., Giuliante, F., Vellone, M., & Nuzzo, G. (1999) · Intensive Care Medicine · doi:10.1007/s001340050940 · Cited by 80
Lind, L., & Lithell, H. (1994) · PubMed · Cited by 62
Endogenous lipoproteins impact the response to endotoxin in humans
Harris, H. W., Johnson, J. A., & Wigmore, S. J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00004 · Cited by 56
Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat
Lanza‐Jacoby, S., Wong, S. H., Tabares, A., Baer, D. J., & Schneider, T. G. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90134-h · Cited by 47
Patterns and Problems of Adult Total Parenteral Nutrition Use in US Academic Medical Centers
Schloerb, P. R. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.1.7 · Cited by 39
Survival in Patients With Type 2 Diabetes in a Swedish Community
Östgren, C. J., Lindblad, U., Melander, A., & Råstam, L. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1297 · Cited by 36
Sterol-regulatory-element-binding protein I c mediates insulin action on hepatic gene expression
Ferré, P., Foretz, M., Azzout‐Marniche, D., Bécard, D., & Foufelle, F. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290547 · Cited by 33
Lipoprotein heterogeneity: diagnostic and therapeutic implications
Kwiterovich, P. O. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02796-0 · Cited by 32
Picard, F., Kapur, S., Perreault, M., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0830fje · Cited by 31
Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition
Donmoyer, C. M., Chen, S., Lacy, D. B., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00035.2002 · Cited by 14
Cited by
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Self-citationRussell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,048
How does blood glucose control with insulin save lives in intensive care?
Van den Berghe, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423506 · Cited by 550
Self-citationAcute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects
Turina, M., Fry, D. E., & Polk, H. C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000170106.61978.d8 · Cited by 490
Intensive insulin therapy protects the endothelium of critically ill patients
Langouche, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25385 · Cited by 467
Metadata
- Authors
- Mesotten, D., Swinnen, J. V., Vanderhoydonc, F., Wouters, P. J., & Van den Berghe, G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-01-01
- Volume
- 89
- Issue
- 1
- Pages
- 219-226
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126091013
- Cited by
- 288
- References
- 39
- FWCI
- 22.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.